Allergy Therapeutics files allergy vaccine in EU
This article was originally published in Scrip
Executive Summary
Allergy Therapeutics has submitted its lead therapeutic allergy vaccine Pollinex Quattro Grass, which is intended to reduce hayfever symptoms caused by grass pollen, for regulatory approval in the EU.